By selectively targeting tumor-associated macrophages (TAMs) within the peritoneal cavity, which play a critical role in promoting tumor growth and suppressing the immune response, the nanoparticles transported the anti-PD-L1 Abs to the intended site. This evidence concerns the gene CD274 and neoplasm.